Lycia Therapeutics Inc.

LYCA Healthcare Biotechnology

30.50 1.70 +5.90%
Market cap
$1.7B
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Columns are period end dates